Magdalena Castellvi
Overview
Explore the profile of Magdalena Castellvi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
212
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Montagut N, Borrego-Ecija S, Herrero J, Castellvi M, Balasa M, Llado A, et al.
J Speech Lang Hear Res
. 2024 Sep;
67(10):3762-3777.
PMID: 39302879
Purpose: Primary progressive aphasia (PPA) is a neurodegenerative disorder characterized by worsening of speech and/or language. Script training intervention promotes automatized speech production via repeated practice of scripted content. This...
2.
Forno G, Contador J, Perez-Millan A, Guillen N, Falgas N, Sarto J, et al.
Eur J Neurol
. 2022 Dec;
30(3):597-605.
PMID: 36463489
Background And Purpose: How the APOE genotype can differentially affect cortical and subcortical memory structures in biomarker-confirmed early-onset (EOAD) and late-onset (LOAD) Alzheimer's disease (AD) was assessed. Method: Eighty-seven cerebrospinal...
3.
Tort-Merino A, Falgas N, Allen I, Balasa M, Olives J, Contador J, et al.
Ann Clin Transl Neurol
. 2022 Nov;
9(12):1962-1973.
PMID: 36398437
Objectives: Early- and late-onset Alzheimer's disease (EOAD and LOAD) share the same neuropathological traits but show distinct cognitive features. We aimed to explore baseline and longitudinal outcomes of global and...
4.
Contador J, Perez-Millan A, Guillen N, Sarto J, Tort-Merino A, Balasa M, et al.
Eur J Neurol
. 2022 Aug;
29(12):3623-3632.
PMID: 36005384
Background And Purpose: Sex is believed to drive heterogeneity in Alzheimer's disease (AD), although evidence in early-onset AD (EOAD; <65 years) is scarce. Methods: We included 62 EOAD patients and...
5.
Contador J, Perez-Millan A, Guillen N, Tort-Merino A, Balasa M, Falgas N, et al.
J Neurol
. 2021 Oct;
269(5):2573-2583.
PMID: 34665329
Background: MRI atrophy predicts cognitive status in AD. However, this relationship has not been investigated in early-onset AD (EOAD, < 65 years) patients with a biomarker-based diagnosis. Methods: Forty eight...
6.
Contador J, Perez-Millan A, Tort-Merino A, Balasa M, Falgas N, Olives J, et al.
Neuroimage Clin
. 2021 Sep;
32:102804.
PMID: 34474317
There is evidence of longitudinal atrophy in posterior brain areas in early-onset Alzheimer's disease (EOAD; aged < 65 years), but no studies have been conducted in an EOAD cohort with...
7.
Montagut N, Borrego-Ecija S, Castellvi M, Rico I, Rene R, Balasa M, et al.
J Alzheimers Dis
. 2020 Dec;
79(1):415-422.
PMID: 33285632
Background: The semantic variant of primary progressive aphasia (svPPA) is characterized by a progressive loss of semantic knowledge impairing the ability to name and to recognize the meaning of words....
8.
Ramos-Campoy O, Antonell A, Falgas N, Balasa M, Borrego-Ecija S, Rodriguez-Santiago B, et al.
Neurobiol Aging
. 2020 Apr;
93:e1-e9.
PMID: 32317127
Early-onset Alzheimer's disease (EOAD) and frontotemporal dementia (FTD) have a high proportion of genetically determined cases. Next-generation sequencing technologies have triggered the discovery of new mutations and genetic variants in...
9.
Diagnostic Accuracy of MRI Visual Rating Scales in the Diagnosis of Early Onset Cognitive Impairment
Falgas N, Balasa M, Bargallo N, Borrego-Ecija S, Ramos-Campoy O, Fernandez-Villullas G, et al.
J Alzheimers Dis
. 2020 Jan;
73(4):1575-1583.
PMID: 31958089
Background: The diagnosis of incipient symptomatic stages of early-onset dementia is challenging. The magnetic resonance imaging (MRI) is an easy-access biomarker. Objective: We aim to determine the distribution and diagnostic...
10.
Falgas N, Ruiz-Peris M, Perez-Millan A, Sala-Llonch R, Antonell A, Balasa M, et al.
Hum Brain Mapp
. 2020 Jan;
41(8):2004-2013.
PMID: 31944489
Prior studies have described distinct patterns of brain gray matter and white matter alterations in Alzheimer's disease (AD) and frontotemporal lobar degeneration (FTLD), as well as differences in their cerebrospinal...